# Photodynamic Strategies for Prevention of Titanium Osteoimplant Infections

**Authors:** Junfeng Wang, Lian Guan, Weilin Sang, Libo Zhu, Guoqing Pan, Tao Wang, Jinzhong Ma

PMC · DOI: 10.34133/research.1092 · 2026-02-16

## TL;DR

This paper reviews photodynamic therapy (PDT) as a promising alternative to antibiotics for preventing infections in titanium orthopedic implants.

## Contribution

The paper provides a comprehensive review of PDT mechanisms and strategies for improving antibacterial performance in titanium implants.

## Key findings

- PDT effectively eradicates biofilm-forming bacteria without promoting antibiotic resistance.
- Optimizing PDT systems and developing new photosensitizers can enhance antibacterial performance.
- Combining PDT with other treatments and improving oxygen supply are key to overcoming current limitations.

## Abstract

The growing demand for orthopedic implants, driven by an aging global population and the rising occurrence of bone abnormalities and defects, relies heavily on biocompatible titanium (Ti) and its alloys. However, their inherent biological inertness often results in poor osseointegration and increased vulnerability to bacterial infections, particularly those caused by biofilm-forming pathogens. Traditional antibiotic treatments frequently fail against biofilms and contribute to the escalating problem of antibiotic resistance, emphasizing the need for alternative therapies that do not foster resistance. Photodynamic therapy (PDT), which uses light-activated photosensitizers to generate reactive oxygen species (ROS) for effective bacterial eradication, presents a promising noninvasive strategy with high precision and low likelihood of resistance development. This review thoroughly explores the mechanisms of PDT and its application to Ti implants, focusing on both organic and inorganic photosensitizers. Moreover, considering current challenges, the study investigates approaches to improve PDT’s effectiveness in combating implant-related infections. These include optimizing PDT systems, developing new AIE-active photosensitizers, increasing oxygen supply to boost ROS production, combining multi-modal antibacterial treatments, and designing dual-functional implants. The review aims to identify current limitations and propose future directions, offering valuable insights to advance PDT-based strategies that enhance the antibacterial performance of Ti implants in the post-antibiotic era.

## Full-text entities

- **Genes:** catalase [NCBI Gene 28381092], Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, alkaline phosphatase [NCBI Gene 28379728], superoxide dismutase [NCBI Gene 28380859], MED1 (mediator complex subunit 1) [NCBI Gene 5469] {aka CRSP1, CRSP200, DRIP205, DRIP230, PBP, PPARBP}, Runx2 (runt related transcription factor 2) [NCBI Gene 12393] {aka AML3, CBF-alpha-1, Cbf, Cbfa-1, Cbfa1, LS3}, peroxidase [NCBI Gene 28379326], Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, CAT [NCBI Gene 6155852], Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}
- **Diseases:** osteoarthritis (MESH:D010003), hyperthermia (MESH:D005334), MRSA (MESH:D013203), periprosthetic joint infection (MESH:D057068), hypoxia (MESH:D000860), skin burns (MESH:D002056), bacterial (MESH:D001424), implant (MESH:D057873), hypoxic (MESH:D002534), microbial infections (MESH:D015163), phototoxic (MESH:D017484), biofilm infection (MESH:D007239), skeletal disorders (MESH:C564967), cancer (MESH:D009369), cytotoxicity (MESH:D064420), bone abnormalities (MESH:D001847), wound infections (MESH:D014946), acidosis (MESH:D000138), osteoporotic (MESH:D058866), osteosarcoma (MESH:D012516), periodontitis (MESH:D010518), arthritis (MESH:D001168), inflammation (MESH:D007249), diabetic abscess (MESH:D000038), traumatic injuries (MESH:D014947), defects (MESH:D000013), bone cancer (MESH:D001859), carcinogenic (MESH:D011230), skin (MESH:D012871), aseptic loosening (MESH:D011475)
- **Chemicals:** BODIPY (MESH:C095489), halogen (MESH:D006219), Ag (MESH:D012834), dopamine (MESH:D004298), PDA (MESH:C568283), Bi2WO6 (MESH:C000626718), Nb (MESH:D009556), AgBiS2 (MESH:C528168), methacrylate (MESH:D008689), MPDA (MESH:C056728), eosin (MESH:D004801), MIL-101 (MESH:C000589635), Mo (MESH:D008982), hydrogen (MESH:D006859), HCl (MESH:D006851), MXene (MESH:C000723374), Copper (MESH:D003300), tryptophan (MESH:D014364), CNPs (MESH:C010422), CaO2 (MESH:C403632), Ce6 (MESH:C062985), NO (MESH:D009569), Yb (MESH:D015018), polyethylene (MESH:D020959), magnesium (MESH:D008274), TBO (MESH:D014048), amoxicillin (MESH:D000658), methicillin (MESH:D008712), N-nitrosamines (MESH:D009602), glucose (MESH:D005947), Mn (MESH:D008345), Cu-TCPP (MESH:C063213), Phenothiazine (MESH:C031637), Ca (MESH:D002118), mPL (MESH:C048436), heavy metal (MESH:D019216), oxide (MESH:D010087), Co3O4 (MESH:C000711807), ROS (MESH:D017382), strontium (MESH:D013324), glycine (MESH:D005998), UiO-66 (MESH:C000711576), hydroxyl radicals (MESH:D017665), QACs (MESH:D000644), ATP (MESH:D000255), H2O (MESH:D014867), phospholipids (MESH:D010743), rare earth (MESH:D008674), NaGdF4 (MESH:C000656715), Copper sulfides (MESH:C017846), Schiff base (MESH:D012545), Bi2S3 (MESH:C049897), ZnO (MESH:D015034), MnO2 (MESH:C016552), peroxynitrite (MESH:D030421), F (MESH:D005461), NaH (MESH:C025451), FMN (MESH:D005486), CeO2 (MESH:C030583), Si-Pc (MESH:C082854)
- **Species:** aureus [taxon 46170], Curcuma longa (turmeric, species) [taxon 136217], Enterococcus faecalis (species) [taxon 1351], Bos taurus (bovine, species) [taxon 9913], Limosilactobacillus fermentum (species) [taxon 1613], Staphylococcus aureus (species) [taxon 1280], Rattus norvegicus (brown rat, species) [taxon 10116], Pseudomonas aeruginosa (species) [taxon 287], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Porphyromonas gingivalis (species) [taxon 837], Aggregatibacter actinomycetemcomitans (species) [taxon 714], Escherichia coli (E. coli, species) [taxon 562]
- **Cell lines:** MoS2 — Aedes aegypti (Yellowfever mosquito), Spontaneously immortalized cell line (CVCL_Z354), MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12907475/full.md

---
Source: https://tomesphere.com/paper/PMC12907475